BioMarin Pharmaceutical Inc.
BioMarin develops & commercializes therapies for rare, life‑threatening diseases including mucopolysaccharidosis and phenylketonuria, with a robust pipeline of enzyme replacement and gene‑therapy candidates worldwide.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Hospitals
- Employees: 3,040
- HQ: San Rafael
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.